Teva Drops Azilect Patent Claim Against Watson, Mylan
A New Jersey federal judge on Wednesday signed off on the dismissal of one of two infringement claims Teva Pharmaceutical Industries Ltd. had brought against Watson Laboratories Inc. and Mylan Inc....To view the full article, register now.
Already a subscriber? Click here to view full article